Spiriva vs Trelegy
What to choose Spiriva or Trelegy
Spiriva is inhaler of type Control while Trelegy is of Control type. Spiriva and Trelegy are both brand inhalers. Spiriva is manufactured by pharmaceutical company Boehringer Ingelheim, while Trelegy is manufactured by GSK. The main substance of Spiriva is Tiotropium. The available dosage for Spiriva is 9 mcg. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg.
The average price for Spiriva is approximately $423 while average price for Trelegy is approximately $619.92, said Simon Gutierrez, a Postdoctoral Researcher at the Washington & Lee University and a Medical Director at a clinic that uses Spiriva and Trelegy.
Spiriva and Trelegy Comparison
| Spiriva | Trelegy | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Boehringer Ingelheim | GSK |
| Substance: | Tiotropium | Fluticasone + Vilanterol |
| Dosage: | 9 mcg | 100 mcg / 25 mcg |
| Avg Price: | $423 | $619.92 |